title: Drug-induced systemic lupus erythematosus and TNF-alpha blockers.
authors.forename: Aparna K
authors.initials: AK
authors.lastname: Mohan
authors.forename: Evelyne T
authors.initials: ET
authors.lastname: Edwards
authors.forename: Timothy R
authors.initials: TR
authors.lastname: Coté
authors.forename: Jeffrey N
authors.initials: JN
authors.lastname: Siegel
authors.forename: M Miles
authors.initials: MM
authors.lastname: Braun
mesh_terms: D000328:Adult; D000974:Antibodies, Antinuclear / Q000097:blood; D017152:Antibodies, Antiphospholipid / Q000097:blood; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000494:pharmacology; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects* / Q000494:pharmacology; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000494:pharmacology; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D018124:Receptors, Tumor Necrosis Factor
chemical_list: D000974:Antibodies, Antinuclear; D017152:Antibodies, Antiphospholipid; D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept